Bond, I think more research on fast track, that 60 day quote did not work for me. My guess if one took NDA submission time plus fast track approval in a super fast finish, I think 8 months at least.
The part I look for is early termination of phase 3. I very much doubt if termination in 2018, good chance in 2019. I suspect minimum of mature data on 100 patients, maybe 100 patients reached earlier this year, I hope so, then one year for maturity.